G007-LK, with the CAS number 1380672-07-0, is a synthetic compound that has garnered attention in the field of medicinal chemistry, particularly for its potential applications in the treatment of various diseases. It is characterized by its unique molecular structure, which includes specific functional groups that contribute to its biological activity. G007-LK has been studied for its role as a selective inhibitor of certain enzymes, which may play a crucial role in disease pathways. The compound exhibits properties such as solubility in organic solvents and stability under standard laboratory conditions. Its mechanism of action typically involves modulation of cellular processes, making it a candidate for further research in drug development. Safety and toxicity profiles are essential considerations in its evaluation, and ongoing studies aim to elucidate its pharmacokinetics and pharmacodynamics. Overall, G007-LK represents a promising area of exploration in therapeutic interventions, although comprehensive studies are necessary to fully understand its potential benefits and limitations.

G007-LK

1380672-07-0: G007-LK, with the CAS number 1380672-07-0, is a synthetic compound that has garnered attention in the field of medicinal chemistry, particularly for its potential applications in the treatment of various diseases. It is characterized by its unique molecular structure, which includes specific functional groups that contribute to its biological activity. G007-LK has been studied for its role as a selective inhibitor of certain enzymes, which may play a crucial role in disease pathways. The compound exhibits properties such as solubility in organic solvents and stability under standard laboratory conditions. Its mechanism of action typically involves modulation of cellular processes, making it a candidate for further research in drug development. Safety and toxicity profiles are essential considerations in its evaluation, and ongoing studies aim to elucidate its pharmacokinetics and pharmacodynamics. Overall, G007-LK represents a promising area of exploration in therapeutic interventions, although comprehensive studies are necessary to fully understand its potential benefits and limitations.

Benzonitrile, 4-[5-[(1E)-2-[4-(2-chlorophenyl)-5-[5-(methylsulfonyl)-2-pyridinyl]-4H-1,2,4-triazol-3-yl]ethenyl]-1,3,4-oxadiazol-2-yl]-

<p>G007-LK is a selective inhibitor of TNKS1 and TNKS2, with IC50s of 46 nM and 25 nM, respectively.</p>

CAS 1380672-07-0

G007-LK

Benzonitrile, 4-[5-[(1E)-2-[4-(2-chlorophenyl)-5-[5-(methylsulfonyl)-2-pyridinyl]-4H-1,2,4-triazol-3-yl]ethenyl]-1,3,4-oxadiazol-2-yl]-

Ref: IN-DA0017XO

G007-LK

Ref: 54-BUP03860

G007-LK

Ref: TM-T6842